Axim Biotechnologies, Inc. SEC filings AXIM
Axim Biotechnologies, Inc. has 306 filings in SEC EDGAR's recent list, going back to Mar 10, 2011. Its latest annual report, Form 10-K, was filed on Apr 16, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2024, covering the quarter ended Jun 30, 2024. The most recent current report (Form 8-K) was filed on Oct 15, 2024 (change in control, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15-12G | Deregistration | Dec 6, 2024 | — |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | Nov 13, 2024 | Sep 30, 2024 |
| NT 10-Q | Axim biotechnologies form 12b-25 | Aug 13, 2024 | Jun 30, 2024 |
| NT 10-Q | Axim biotechnologies form 12b-25 | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Axim biotechnologies, inc. - nt 10k | Apr 1, 2024 | Dec 31, 2023 |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | Nov 14, 2023 | Sep 30, 2023 |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | Aug 14, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | May 15, 2023 | Mar 31, 2023 |
| NT 10-K | Axim biotechnologies, inc. - nt 10k | Mar 31, 2023 | Dec 31, 2022 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | Aug 16, 2022 | Jun 30, 2022 |
| EFFECT | Filing | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Aug 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | May 17, 2022 | Mar 31, 2022 |
| NT 10-K | Axim biotechnologies, inc. form 12b-25 | Mar 31, 2022 | Dec 31, 2021 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | Nov 15, 2021 | Sep 30, 2021 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | Aug 16, 2021 | Jun 30, 2021 |
| EFFECT | Filing | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | May 19, 2021 | — |
| NT 10-Q | Form nt 10-q notice of late quarterly filing | May 14, 2021 | Mar 31, 2021 |
| NT 10-K | Form 12b-25 notice of late filing | Mar 30, 2021 | Dec 31, 2020 |
| NT 10-Q | Form 12b-25 notice of late filing | Nov 16, 2020 | Sep 30, 2020 |
| NT 10-Q | Form 12b25 extension | Jun 29, 2020 | Mar 31, 2020 |
| D | Filing | Jun 15, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2020 | — |
| CORRESP | Letter to the SEC | Dec 23, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2019 | — |
| CORRESP | Letter to the SEC | Oct 29, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2019 | — |
| NT 10-K | Form nt 10-k notice of late filing | Apr 1, 2019 | Dec 31, 2018 |
| D | Filing | May 21, 2018 | — |
| NT 10-Q | Form nt 10-q notice of late quarterly filing | Nov 15, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Sep 14, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2017 | — |
| CORRESP | Letter to the SEC | Sep 11, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2017 | — |
| NT 10-Q | Form nt 10q notice of late quarterly filing | Aug 14, 2017 | Jun 30, 2017 |
| NT 10-Q | Form12b25 notice of late filing | May 16, 2017 | Mar 31, 2017 |
| NT 10-K | Form12b25 notice of late filing | Mar 31, 2017 | Dec 31, 2016 |
| NT 10-Q | Form12b25 notice of late filing | Nov 14, 2016 | Sep 30, 2016 |
| NT 10-Q | Form12b25 notice of late filing | Aug 16, 2016 | Jun 30, 2016 |
| NT 10-Q | Form 12b-25 | May 13, 2016 | Mar 31, 2016 |
| NT 10-K | Filing | Mar 30, 2016 | Dec 31, 2015 |
| NT 10-Q | Form 12b-25 | Nov 16, 2015 | Sep 30, 2015 |
| NT 10-Q | Filing | Aug 14, 2015 | Jun 30, 2015 |
| NT 10-K | Form 12b-25 | Mar 31, 2015 | Dec 31, 2014 |
| D | Filing | Oct 23, 2014 | — |
| NT 10-Q | Form 12b-25 (6-30-14) | Aug 13, 2014 | Jun 30, 2014 |
| UPLOAD | Letter from the SEC | Jul 7, 2014 | — |
| CORRESP | Letter to the SEC | Jun 30, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2014 | — |
| PRER14C | Schedule 14c | Jun 16, 2014 | — |
| CORRESP | Letter to the SEC | Jun 13, 2014 | — |
| CORRESP | Letter to the SEC | Jun 9, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2014 | — |
| CORRESP | Letter to the SEC | May 29, 2014 | — |
| UPLOAD | Letter from the SEC | May 28, 2014 | — |
| CORRESP | Letter to the SEC | May 23, 2014 | — |
| UPLOAD | Letter from the SEC | May 20, 2014 | — |
| NT 10-Q | Form 12b-25 (3-31-14) | May 14, 2014 | Mar 31, 2014 |
| NT 10-Q | Filing | Nov 8, 2013 | Sep 30, 2013 |
| NT 10-Q | Filing | Aug 12, 2013 | Jun 30, 2013 |
| NT 10-Q | Filing | May 13, 2013 | Mar 31, 2013 |
| NT 10-K | Filing | Mar 28, 2013 | Dec 31, 2012 |
| NT 10-Q | Filing | Nov 9, 2012 | Sep 30, 2012 |
| NT 10-Q | Filing | Aug 14, 2012 | Jun 30, 2012 |
| NT 10-Q | Filing | May 14, 2012 | Mar 31, 2012 |
| NT 10-K | Filing | Mar 26, 2012 | Dec 31, 2011 |
| NT 10-Q | Filing | Nov 9, 2011 | Sep 30, 2011 |
| UPLOAD | Letter from the SEC | Sep 1, 2011 | — |
| 10-12G/A | Filing | Jul 7, 2011 | — |
| 10-12G/A | Filing | Jun 14, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2011 | — |
| 10-12G | Filing | May 13, 2011 | — |
| 15-12G | Deregistration | May 6, 2011 | — |
| 10-12G/A | Filing | Apr 19, 2011 | — |
| 10-12G | Filing | Mar 10, 2011 | — |
Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXIM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514946
- Former names
- AXIM INTERNATIONAL INC. (until Aug 13, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.